If the patients lose weight, and the ALT levels normalize or clinically meaningfully improve, a NAFLD diagnosis can be strongly suspected, especially if there are parallel improvements in related factors such as triglyceride and HbA1c levels [33]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.